Sunday, October 4, 2026

EUR/CHF Bearish Momentum: 0.9% Down In The Last 5 Sessions

EUR/CHF Bearish Momentum: 0.9% Down In The Last 5 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 0.9% for the last 5 sessions. At 03:06 EST on Friday, 19 July, EUR/CHF (EURCHF) is $0.97.

EUR/CHF's yearly highs and lows, it's 7.065% up from its 52-week low and 2.638% down from its 52-week high.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/CHF's Forex is considered to be overbought (>=80).

News about

  • Eur/usd holds losses near 1.0900 due to increased risk aversion. According to FXStreet on Friday, 19 July, "The decline in the EUR/USD pair can be attributed to the strengthening of the US Dollar (USD) amid increased risk aversion."
  • Eur/usd trades with bearish bias below 1.0950 ahead of ECB rate decision. According to FXStreet on Thursday, 18 July, "The EUR/USD pair trades on a weaker note around 1.0935, snapping a two-day winning streak during the early European session on Thursday. "
  • According to FXStreet on Thursday, 18 July, "Unless the policy statement, or Lagarde, pushes back against this expectation, the market positioning suggests that EUR/USD could have a hard time gathering bullish momentum, with investors already fully pricing in a Fed rate cut in September.", "Heading into the ECB showdown, the Euro preserves its strength, with EUR/USD trading at its highest level since March above 1.0900. "
  • Eur/usd crosses over 1.09 on Wednesday as euro bulls gear up for ECB rate call. According to FXStreet on Wednesday, 17 July, "Fiber tilted into the top end on Wednesday, looking upwards through the midweek trading session and EUR/USD is on pace to chalk in a fourth straight week in the green, assuming buyers are able to maintain topside pressure."
  • Eur/usd: ECB keeps its deposit rate unchanged – TDS. According to FXStreet on Thursday, 18 July, "For now, we think the USD has lots of bad news priced in, suggesting that EUR/USD provides good entry levels to fade the recent rally. "

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,340 source documents archived
Query this data → isubstrate.com